Top Industry News
- FDA Issues Draft Guidance on Biosimilar Licensing and Labeling, Timing of Certain Supplement Reviews
- FDA Releases Small Entity Compliance Guide on the Nutrition and Supplement Facts Labels
- Recommendations from Danish Medicines Agency on Applications for Authorisation of Clinical Investigation of Medical Devices
- ANVISA- CTD Guide: Deadline for Suggestions Ends 2/14
- SFDA- The GCC Guidelines for Variation Requirements (Draft)
- ANVISA- Public Notice Launched on Registration of Similar Drugs
- FDA- Biologic and Biosimilar Misinformation: FDA Drafts Guidance